Humacyte, Inc. (HUMAW) — SC 13D/A Filings

SC 13D/A Filings (6)

• Humacyte 13D/A Amendment Filed — Nov 20, 2024 Risk: low
  Laura E. Niklason and Brady W. Dougan filed an amendment (No. 9) to their Schedule 13D for Humacyte, Inc. on November 20, 2024. This filing relates to their ben
• Fresenius Medical Care Amends Humacyte Stake Filing — Nov 18, 2024 Risk: medium
  Fresenius Medical Care Holdings Inc. has amended its Schedule 13D filing regarding Humacyte, Inc. The filing, dated November 18, 2024, indicates a change in ben
• Humacyte, Inc. Ownership Filing Amendment — Sep 3, 2024 Risk: medium
  Laura E. Niklason and Brady W. Dougan have filed an amendment (Amendment No. 8) to their Schedule 13D for Humacyte, Inc., reporting changes as of August 29, 202
• Humacyte Stakeholders File 13D/A Amendment — Jun 4, 2024 Risk: medium
  Laura E. Niklason and Brady W. Dougan, through Ayabudge LLC, filed an amendment to their Schedule 13D on May 31, 2024, regarding their holdings in Humacyte, Inc
• Humacyte Inc. 13D/A Filing Update — Mar 8, 2024 Risk: medium
  Laura E. Niklason and Brady W. Dougan, through Ayabudge LLC, have amended their Schedule 13D filing concerning Humacyte, Inc. The amendment, filed on March 8, 2
• Fresenius Medical Care Amends Humacyte Stake Filing — Mar 7, 2024 Risk: medium
  Fresenius Medical Care Holdings Inc. /NY/ has amended its Schedule 13D filing regarding Humacyte, Inc. as of March 7, 2024. This amendment, designated as Amendm

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX